1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association between the atherogenic index of plasma trajectory and risk of heart failure among hypertensive patients: a prospective cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The atherogenic index of plasma (AIP) has been shown to be positively correlated with cardiovascular events. However, it remains unclear whether hypertensive patients with long-term high AIP levels are at greater risk of developing heart failure (HF). Therefore, the aim of this study was to investigate the association between AIP trajectory and the incidence of HF in hypertensive patients.

          Methods

          This prospective study included 22,201 hypertensive patients from the Kailuan Study who underwent three waves of surveys between 2006 and 2010. Participants were free of HF or cancer before or during 2010. The AIP was calculated as the logarithmic conversion ratio of triglycerides to high-density lipoprotein cholesterol. Latent mixed modeling was employed to identify different trajectory patterns for AIP during the exposure period (2006–2010). Cox proportional hazard models were then used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for incident HF among different trajectory groups.

          Results

          Four distinct trajectory patterns were identified through latent mixture modeling analysis: low-stable group ( n = 3,373; range, -0.82 to -0.70), moderate-low stable group ( n = 12,700; range, -0.12 to -0.09), moderate-high stable group ( n = 5,313; range, 0.53 to 0.58), and elevated-increasing group ( n = 815; range, 1.22 to 1.56). During a median follow-up period of 9.98 years, a total of 822 hypertensive participants experienced HF. After adjusting for potential confounding factors, compared with those in the low-stable group, the HR and corresponding CI for incident HF in the elevated-increasing group, moderate-high stable group, and moderate-low stable group were estimated to be 1.79 (1.21,2.66), 1.49 (1.17,1.91), and 1.27 (1.02,1.58), respectively. These findings remained consistent across subgroup analyses and sensitivity analyses.

          Conclusion

          Prolonged elevation of AIP in hypertensive patients is significantly associated with an increased risk of HF. This finding suggests that regular monitoring of AIP could aid in identifying individuals at a heightened risk of HF within the hypertensive population.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12933-024-02375-z.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: not found
          • Article: not found

          Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

          (2002)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

            "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" provides a new guideline for hypertension prevention and management. The following are the key messages(1) In persons older than 50 years, systolic blood pressure (BP) of more than 140 mm Hg is a much more important cardiovascular disease (CVD) risk factor than diastolic BP; (2) The risk of CVD, beginning at 115/75 mm Hg, doubles with each increment of 20/10 mm Hg; individuals who are normotensive at 55 years of age have a 90% lifetime risk for developing hypertension; (3) Individuals with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to 89 mm Hg should be considered as prehypertensive and require health-promoting lifestyle modifications to prevent CVD; (4) Thiazide-type diuretics should be used in drug treatment for most patients with uncomplicated hypertension, either alone or combined with drugs from other classes. Certain high-risk conditions are compelling indications for the initial use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); (5) Most patients with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg for patients with diabetes or chronic kidney disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration should be given to initiating therapy with 2 agents, 1 of which usually should be a thiazide-type diuretic; and (7) The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated. Motivation improves when patients have positive experiences with and trust in the clinician. Empathy builds trust and is a potent motivator. Finally, in presenting these guidelines, the committee recognizes that the responsible physician's judgment remains paramount.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global burden of heart failure: a comprehensive and updated review of epidemiology

              Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality of life, and high costs. HF affects more than 64 million people worldwide. Therefore, attempts to decrease its social and economic burden have become a major global public health priority. While the incidence of HF has stabilized and seems to be declining in industrialized countries, the prevalence is increasing due to the ageing of the population, improved treatment of and survival with ischaemic heart disease, and the availability of effective evidence-based therapies prolonging life in patients with HF. There are geographical variations in HF epidemiology. There is substantial lack of data from developing countries, where HF exhibits different features compared with that observed in the Western world. In this review, we provide a contemporary overview on the global burden of HF, providing updated estimates on prevalence, incidence, outcomes, and costs worldwide.
                Bookmark

                Author and article information

                Contributors
                drwusl@163.com
                yrchen3@stu.edu.cn
                Journal
                Cardiovasc Diabetol
                Cardiovasc Diabetol
                Cardiovascular Diabetology
                BioMed Central (London )
                1475-2840
                16 August 2024
                16 August 2024
                2024
                : 23
                : 301
                Affiliations
                [1 ]Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, ( https://ror.org/035rs9v13) 69 Dongxia North Road, Shantou, 515000 China
                [2 ]Shantou University Medical College, ( https://ror.org/02gxych78) Shantou, China
                [3 ]Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, ( https://ror.org/01px77p81) Guangzhou, China
                [4 ]Department of Physiology, Temerty Faculty of Medicine, University of Toronto, ( https://ror.org/03dbr7087) Toronto, Ontario Canada
                [5 ]GRID grid.4830.f, ISNI 0000 0004 0407 1981, Department of Epidemiology, University Medical Center Groningen, , University of Groningen, ; Groningen, the Netherlands
                [6 ]Department of Cardiology, Kailuan General Hospital, ( https://ror.org/01kwdp645) 57 Xinhua East Road, Tangshan, 063000 China
                Article
                2375
                10.1186/s12933-024-02375-z
                11330004
                39152490
                a9d36b7b-b6f3-431c-b462-e1078c231ff8
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

                History
                : 7 May 2024
                : 24 July 2024
                Funding
                Funded by: Science and Technology Innovation Strategy Special Project of Guangdong
                Award ID: 221117237489175
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2024

                Endocrinology & Diabetes
                atherogenic index of plasma,trajectory,heart failure,hypertension
                Endocrinology & Diabetes
                atherogenic index of plasma, trajectory, heart failure, hypertension

                Comments

                Comment on this article